- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Benign Prostatic Hyperplasia in United Kingdom
Total 4549 results
-
Institute of Cancer Research, United KingdomProstate Cancer UKRecruitingProstate CancerUnited Kingdom
-
Hull University Teaching Hospitals NHS TrustCompleted
-
Astellas Pharma IncAstellas Pharma US, Inc.CompletedProstate Cancer | Cancer of the Prostate | Prostatic Cancer | Cancer of ProstateNetherlands, United States, United Kingdom
-
University College, LondonCompletedProstate CancerUnited Kingdom
-
Lancashire Teaching Hospitals NHS Foundation TrustCompletedProstate Cancer | Radiotherapy Side EffectUnited Kingdom
-
Institute of Cancer Research, United KingdomRoyal Marsden NHS Foundation Trust; University of Oxford; Queen Mary University... and other collaboratorsRecruitingProstate Cancer | Genetic Counselling | Genetic Markers | Prostate BiopsyUnited Kingdom
-
Institute of Cancer Research, United KingdomRoyal Marsden NHS Foundation Trust; Nottingham University Hospitals NHS Trust; Barts & The London NHS Trust and other collaboratorsRecruitingHormone Refractory Prostate CancerUnited Kingdom
-
The Leeds Teaching Hospitals NHS TrustUnknownProstate CancerUnited Kingdom
-
Royal Marsden NHS Foundation TrustUnknownProstate CancerUnited Kingdom
-
University Hospitals of North Midlands NHS TrustCompletedProstate CarcinomaUnited Kingdom
-
University College, LondonCompletedProstate Cancer | MR Image Distortion CorrectionUnited Kingdom
-
University College London HospitalsUnknownSexual Dysfunction | Prostate CancerUnited Kingdom
-
Royal Surrey County Hospital NHS Foundation TrustCompletedProstatic Neoplasms | Cancer of the ProstateUnited Kingdom
-
CCTU- Cancer ThemeJanssen-Cilag Ltd.Completed
-
Cancer Research UKTerminatedProstate CancerUnited Kingdom
-
University of StirlingProstate Cancer UKCompleted
-
Cancer Research UKUnknownProstate CancerUnited Kingdom
-
University of BirminghamMedical Research Council; Janssen, LP; Department of Health, United KingdomCompleted
-
Royal Marsden NHS Foundation TrustRecruiting
-
Ferring PharmaceuticalsCompletedLower Urinary Tract Symptoms (LUTS)United States, Canada, Belgium, Czech Republic, Italy, Poland
-
University of OxfordNational Institute for Health Research, United KingdomRecruiting
-
PfizerCompletedProstatic HyperplasiaAustralia, Denmark, Spain, Colombia, Slovakia, Chile, Canada, Finland, Italy, Poland, Greece, Belgium, United Kingdom, Latvia, Lithuania
-
Cancer Research UKUnknown
-
Royal Marsden NHS Foundation TrustInstitute of Cancer Research, United KingdomUnknown
-
Cougar Biotechnology, Inc.CompletedProstate NeoplasmsUnited Kingdom, United States
-
University Hospitals of North Midlands NHS TrustCompletedCancer of the ProstateUnited Kingdom
-
Queen Mary University of LondonCancer Research UK; Barts and the London School of Medicine and DentistryCompletedProstate CancerUnited Kingdom
-
MedImmune LLCCompletedMetastatic Castration Resistant Prostate CancerUnited States, Switzerland, United Kingdom
-
Cougar Biotechnology, Inc.CompletedProstate NeoplasmsUnited States, United Kingdom
-
Guy's and St Thomas' NHS Foundation TrustQueen's University, Belfast; University of Bristol; University of Glasgow; University... and other collaboratorsRecruitingProstate CancerUnited Kingdom
-
The Christie NHS Foundation TrustProstate Cancer UKRecruitingHypoxia | Prostate CancerUnited Kingdom
-
Imperial College LondonImperial College Healthcare NHS Trust; Experimental Cancer Medicine CentresRecruitingObesity | Prostate CancerUnited Kingdom
-
InSightecTerminatedProstate CancerChina, Canada, United Kingdom
-
InSightecCompletedLocalized Low-Intermediate Risk Prostate CancerUnited Kingdom, Israel, Canada, Italy, Singapore
-
Theragnostics LtdCompletedProstate CancerUnited Kingdom
-
Orion Corporation, Orion PharmaCompletedProstate CancerFinland, France, United Kingdom, Latvia
-
The Methodist Hospital Research InstituteCompleted
-
University College, LondonRecruiting
-
Institute of Cancer Research, United KingdomAstraZeneca; Astellas Pharma Inc; Prostate Cancer UKTerminatedMetastatic Castration Resistant Prostate CancerUnited Kingdom, Switzerland
-
Institute of Cancer Research, United KingdomRoyal Marsden NHS Foundation Trust; Cancer Research UK; Ronald and Rita McAulay...Active, not recruitingProstate Cancer in BRCA1 and BRCA2 CarriersUnited Kingdom
-
SpectraCure ABRecruitingRecurrent Prostate CancerUnited States, Canada, United Kingdom, Sweden
-
Steba Biotech S.A.CompletedProstate CancerNetherlands, France, United Kingdom
-
Institute of Cancer Research, United KingdomRoyal Marsden NHS Foundation TrustRecruiting
-
Norfolk and Norwich University Hospitals NHS Foundation...University of East AngliaSuspended
-
Institute of Cancer Research, United KingdomCancer Research UKUnknownProstate CancerUnited Kingdom
-
Institute of Cancer Research, United KingdomRoyal Marsden NHS Foundation Trust; Cancer Research UKActive, not recruitingProstate CancerUnited Kingdom
-
AstraZenecaCompleted
-
SanofiCompletedProstate CancerFrance, United Kingdom, United States
-
Celcuity IncRecruitingProstate Cancer | Prostatic Neoplasms, Castration-Resistant | Genital Diseases, Male | Prostatic Disease | mCRPC (Metastatic Castration-resistant Prostate Cancer) | Urogenital Diseases, MaleUnited States, France, Spain, United Kingdom
-
Opna-IO LLCTerminatedMetastatic Castration-resistant Prostate CancerUnited States, United Kingdom